drugset / Trial / NCT03755973
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
Phase 4
Completed
24 enrolled
Instituto Valenciano de Infertilidade de Lisboa
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupOpen-labelDiagnostic
Summary
This study will assess the change in endometrial gene expression signature on the day of embryo transfer according to the type of exogenous gonadotropins administered.
Timeline
- Start
- 2020-01-29
- Primary completion
- 2023-05-22
- Completion
- 2023-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CFA | Unknown | 150 iu | — |
| Subject | Recombinant human follicle stimulating hormone (r-hFSH) | Protein / enzyme biologic | 50 iu | — |
| Subject | Recombinant human follicle stimulating hormone (r-hFSH) | Protein / enzyme biologic | 100 iu | — |
| Subject | Recombinant human follicle stimulating hormone (r-hFSH) | Protein / enzyme biologic | 150 iu | — |
| Subject | Recombinant human follicle stimulating hormone (r-hFSH) | Protein / enzyme biologic | 200 iu | — |
| Subject | Recombinant human follicle stimulating hormone (r-hFSH) | Protein / enzyme biologic | 300 iu | — |